Science education guide to cervical cancer prevention and treatment in China

Cervical cancer remains a significant threat to the health and lives of Chinese women. In 2022 alone, national cancer registry data reported 150 700 new cervical cancer cases and 55 700 deaths, with a global age-standardised incidence rate of 13.83/100 000 and a mortality rate of 4.54/100 000, representing 6.58% and 5.89% of all female cancer cases and deaths, respectively. 1 Since 2000, both incidence and mortality rates in China have continued to rise, with cases increasingly occurring in younger women. Although three-tier prevention and treatment measures for cervical cancer exist, China’s current prevention and treatment service infrastructure remains incomplete. Gaps in women’s health awareness, limited access to relevant information, low rates of human papillomavirus (HPV) vaccination and insufficient cervical cancer screening coverage continue to pose challenges.2 3